Assignee
2SEVENTY BIO INC
US·22 granted patents·26 pending applications·52 citations·filing 2015–2025
Top patents by PatentIndex Score
48 records- 0196US11382965B2BCMA chimeric antigen receptors2SEVENTY BIO INC·Filed 2020·Granted Jul 12, 2022·6 cites·30 claims
- 0296US11351236B2BCMA chimeric antigen receptors2SEVENTY BIO INC·Filed 2020·Granted Jun 7, 2022·7 cites·39 claims
- 0395US11633463B2BCMA chimeric antigen receptors2SEVENTY BIO INC·Filed 2020·Granted Apr 25, 2023·4 cites·24 claims
- 0492US12029784B2BCMA chimeric antigen receptors2SEVENTY BIO INC·Filed 2020·Granted Jul 9, 2024·2 cites·50 claims
- 0592US11560547B2Methods of making T cell compositions2SEVENTY BIO INC·Filed 2019·Granted Jan 24, 2023·5 cites·38 claims
- 0689US11530265B2Multipartite signaling proteins and uses thereof2SEVENTY BIO INC·Filed 2019·Granted Dec 20, 2022·3 cites·26 claims
- 0789US11479755B2T cell compositions2SEVENTY BIO INC·Filed 2015·Granted Oct 25, 2022·5 cites·19 claims
- 0889US11365226B2PD-1 homing endonuclease variants, compositions, and methods of use2SEVENTY BIO INC·Filed 2017·Granted Jun 21, 2022·5 cites·13 claims
- 0989US2025026845A1Bcma chimeric antigen receptors2SEVENTY BIO INC·Filed 2024·Application pending·0 cites
- 1088US11779654B2PCSK9 endonuclease variants, compositions, and methods of use2SEVENTY BIO INC·Filed 2018·Granted Oct 10, 2023·5 cites·15 claims
- 1187US12006369B2BCMA chimeric antigen receptors2SEVENTY BIO INC·Filed 2019·Granted Jun 11, 2024·2 cites·32 claims
- 1285US11732255B2CBLB endonuclease variants, compositions, and methods of use2SEVENTY BIO INC·Filed 2021·Granted Aug 22, 2023·1 cites·15 claims
- 1381US11654158B2TGFBeta signal convertor2SEVENTY BIO INC·Filed 2017·Granted May 23, 2023·5 cites·20 claims
- 1480US2023287111A1Multipartite signaling proteins and uses thereof2SEVENTY BIO INC·Filed 2022·Application pending·0 cites
- 1579US2024417481A1Bcma chimeric antigen receptors2SEVENTY BIO INC·Filed 2024·Application pending·0 cites
- 1677US12247084B2Anti-BCMA CAR antibodies, conjugates, and methods of use2SEVENTY BIO INC·Filed 2019·Granted Mar 11, 2025·1 cites·14 claims
- 1777US2023193202A1Methods for making t cell compositions2SEVENTY BIO INC·Filed 2022·Application pending·0 cites
- 1877US2024401080A1Mnd promoter chimeric antigen receptors2SEVENTY BIO INC·Filed 2024·Application pending·0 cites
- 1976US2024189454A1Pcsk9 endonuclease variants, compositions, and methods of use2SEVENTY BIO INC·Filed 2023·Application pending·0 cites
- 2074US11912746B2PD-1 homing endonuclease variants, compositions, and methods of use2SEVENTY BIO INC·Filed 2022·Granted Feb 27, 2024·0 cites·16 claims
- 2174US2025064722A1Anti-bcma car t cell compositions2SEVENTY BIO INC·Filed 2024·Application pending·0 cites
- 2274US2025064723A1Anti-bcma car t cell compositions2SEVENTY BIO INC·Filed 2024·Application pending·0 cites
- 2372US12109234B2Anti-BCMA CAR T cell compositions2SEVENTY BIO INC·Filed 2017·Granted Oct 8, 2024·1 cites·22 claims
- 2464US12545746B2Anti-BCMA car antibodies, conjugates, and methods of use2SEVENTY BIO INC·Filed 2020·Granted Feb 10, 2026·0 cites·20 claims
- 2562US2025290041A1Methods for manufacturing adoptive cell therapies2SEVENTY BIO INC·Filed 2025·Application pending·0 cites
- 2660US11591582B2TCRα homing endonuclease variants2SEVENTY BIO INC·Filed 2017·Granted Feb 28, 2023·0 cites·15 claims
- 2759US2025197523A1Anti-bcma car antibodies, conjugates, and methods of use2SEVENTY BIO INC·Filed 2025·Application pending·0 cites
- 2858US11952413B2Dimerizing agent regulated immunoreceptor complexes comprising interleukin receptor signaling domains2SEVENTY BIO INC·Filed 2018·Granted Apr 9, 2024·0 cites·7 claims
- 2956US2024261404A1Modified ccr polypeptides and uses thereof2SEVENTY BIO INC·Filed 2021·Application pending·0 cites
- 3056US2024336904A1Compositions and methods for site-directed mutagenesis2SEVENTY BIO INC·Filed 2021·Application pending·0 cites
- 3155US11976116B2Salvage chimeric antigen receptor systems2SEVENTY BIO INC·Filed 2017·Granted May 7, 2024·0 cites·14 claims
- 3255US11499149B2Donor repair templates multiplex genome editing2SEVENTY BIO INC·Filed 2018·Granted Nov 15, 2022·0 cites·19 claims
- 3355US2023212591A1Methods for manufacturing viral vectors2SEVENTY BIO INC·Filed 2021·Application pending·0 cites
- 3455US2024218351A1Single stranded rna purification methods2SEVENTY BIO INC·Filed 2022·Application pending·0 cites
- 3552US2024271107A1Vector manufacturing processes2SEVENTY BIO INC·Filed 2022·Application pending·0 cites
- 3652US2023124640A1T cell receptors2SEVENTY BIO INC·Filed 2021·Application pending·0 cites
- 3752US2022280567A1Compositions and methods for treating cancer2SEVENTY BIO INC·Filed 2020·Application pending·0 cites
- 3851US2022195060A1Manufacturing anti-bcma car t cells2SEVENTY BIO INC·Filed 2020·Application pending·0 cites
- 3951US2022362304A1Adoptive cell therapy2SEVENTY BIO INC·Filed 2020·Application pending·0 cites
- 4050US2022315638A1Cd123 targeted immunotherapies2SEVENTY BIO INC·Filed 2020·Application pending·0 cites
- 4150US2022226374A1Cd79b chimeric antigen receptors2SEVENTY BIO INC·Filed 2019·Application pending·0 cites
- 4250US2024025963A1Dimerizing agent regulated immunoreceptor complexes2SEVENTY BIO INC·Filed 2019·Application pending·0 cites
- 4349US2023031838A1Dimerizing agent regulated immunoreceptor complexes2SEVENTY BIO INC·Filed 2020·Application pending·0 cites
- 4448US12291722B2Methods for manufacturing adoptive cell therapies2SEVENTY BIO INC·Filed 2015·Granted May 6, 2025·0 cites·35 claims
- 4548US2024034768A1Dimerizing agent regulated immunoreceptor complexes2SEVENTY BIO INC·Filed 2019·Application pending·0 cites
- 4645US2023310604A1Bcma chimeric antigen receptors2SEVENTY BIO INC·Filed 2021·Application pending·0 cites
- 4743US11530395B2TGFBetaR2 endonuclease variants, compositions, and methods of use2SEVENTY BIO INC·Filed 2017·Granted Dec 20, 2022·0 cites·19 claims
- 4841US2022218745A1Multivalent chimeric antigen receptor2SEVENTY BIO INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when 2SEVENTY BIO INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →